Federated Hermes, Inc. Uni Qure N.V. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $7.82 Million - $12.2 Million	-594,800 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$14.54 - $21.5 $12.3 Million - $18.2 Million	-848,042 Reduced 58.78%	594,800 $10.7 Million
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $37.4 Million - $66.5 Million	-1,846,819 Reduced 56.14%	1,442,842 $29.9 Million
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $1.29 Million - $1.89 Million	-49,515 Reduced 1.48%	3,289,661 $105 Million
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $3.15 Million - $3.9 Million	-105,000 Reduced 3.05%	3,339,176 $103 Million
Q1 2021 May 13, 2021	SELL	$29.24 - $42.03 $12 Million - $17.3 Million	-411,439 Reduced 10.67%	3,444,176 $116 Million
Q4 2020 Feb 12, 2021	BUY	$35.35 - $50.67 $16.9 Million - $24.2 Million	477,408 Added 14.13%	3,855,615 $139 Million
Q3 2020 Nov 12, 2020	BUY	$35.98 - $47.66 $10 Million - $13.2 Million	277,900 Added 8.96%	3,378,207 $124 Million
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $7.63 Million - $11.5 Million	169,429 Added 5.78%	3,100,307 $140 Million
Q1 2020 May 13, 2020	SELL	$40.01 - $73.97 $3.22 Million - $5.96 Million	-80,568 Reduced 2.68%	2,930,878 $139 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $22,278 - $44,772	600 Added 0.02%	3,011,446 $216 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $49.5 Million - $96.6 Million	1,257,953 Added 71.76%	3,010,846 $119 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $25.4 Million - $39.5 Million	480,665 Added 37.78%	1,752,893 $137 Million
Q1 2019 May 10, 2019	SELL	$27.39 - $68.41 $8.04 Million - $20.1 Million	-293,372 Reduced 18.74%	1,272,228 $75.9 Million
Q3 2018 Nov 13, 2018	BUY	$29.75 - $43.08 $14.1 Million - $20.4 Million	474,320 Added 43.46%	1,565,600 $57 Million
Q2 2018 Aug 10, 2018	BUY	$21.96 - $39.94 $3.81 Million - $6.92 Million	173,281 Added 18.88%	1,091,280 $41.3 Million
Q1 2018 May 09, 2018	BUY	$17.1 - $26.61 $15.7 Million - $24.4 Million	917,999 New	917,999 $21.6 Million

Others Institutions Holding QURE

# of Institutions

154

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

Vestal Point Capital, LP New York, NY

4.75M
Shares

$28.5 Million
1.78% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.78M
Shares

$16.7 Million
0.81% of portfolio
Boxer Capital, LLC San Diego, CA

2.23M
Shares

$13.3 Million
0.58% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.19M
Shares

$13.1 Million
0.01% of portfolio
Abrdn PLC

1.93M
Shares

$11.6 Million
0.02% of portfolio

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $280M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account